A recent study reveals that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt traditional lifestyle regimens.
Findings released in a prominent medical journal shows that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month after stopping.
"Users buying these medications must be informed of the risk of fast weight regain when the therapy ends," stated researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment mass in about one and a half years.
Analyzing Therapies
The study, which reviewed 37 of trials involving over 9,000 of patients, compared the results of these new drugs with older methods.
The team note that individuals who shed pounds through dieting generally experience a less rapid creep back—approximately 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Experts suggest the mechanism of the drugs accounts for the accelerated regain.
The injections copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication results in appetite is no longer kept in check, making binge eating much more probable."
A Lifelong Condition?
Health authorities suggest the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals argue that, considering the likelihood of weight regain, the treatment should be considered long-term.
This view is echoed by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," similar to managing diseases like hypertension.
User Experiences
Individuals who have come off the jabs report a powerful return of hunger.
"I experienced a trigger activating and you're instantly ravenous," described a patient.
The struggle is compounded if individuals have not established permanent lifestyle or habit modifications during treatment.
Growing Use
Survey data show that millions of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Adoption is greater among females than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, experts stress that while these medications are powerful tools for weight loss, they are not a permanent fix and long-term success likely depends on integrated lifestyle changes.
